Chugai Pharmaceutical Ltd Unsponsored ADR share price logo

Chugai Pharmaceutical Ltd Unsponsored ADR

NASDAQ: CHGCY

Large Cap

$23.40

-0.37

(-1.56%)

as on

Chugai Pharmaceutical Ltd Unsponsored ADR Stock Performance

as on June 17, 2026 at 6:57 am IST

  • Day's Low

    Day's High

    $23.34
    $23.96
    downward going graph

    0.26%

    Downside

    2.39%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Chugai Pharmaceutical Ltd Unsponsored ADR share price movements today

Previous Close
$23.77
Open
$23.56
Volume
153.7K
Day's Low - High
$23.34 - $23.96

Chugai Pharmaceutical Ltd Unsponsored ADR Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Chugai Pharmaceutical Ltd Unsponsored ADR Stock Fundamentals & Key Indicators

Check Chugai Pharmaceutical Ltd Unsponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$77.2B

EPS (TTM)

0

Dividend Yield

3.72%

PE Ratio (TTM)

28.61

Industry PE ratio

11.517692307692307

PEG Ratio

2.3013

Return On Equity TTM

23.71%

Chugai Pharmaceutical Ltd Unsponsored ADR Stock Valuation

Track how Chugai Pharmaceutical Ltd Unsponsored ADR P/E has moved over time to understand its valuation trends.

Chugai Pharmaceutical Ltd Unsponsored ADR in the last 5 years

  • Overview

  • Trends

Lowest (0.32x)

December 31, 2025

Industry (11.52x)

June 17, 2026

Today (28.61x)

June 17, 2026

Highest (32.54x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 28.61x

Chugai Pharmaceutical Ltd Unsponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Chugai Pharmaceutical Ltd Unsponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$77.2BNA28.6135.02%3.7199999999999998%
BUY$1.0T405.15%40.1634.99%0.5499999999999999%
BUY$277.6B206.27%26.9217.19%1.81%
BUY$391.5B93.62%108.625.79%2.96%
BUY$567.3B42.34%27.3121.83%2.16%

Chugai Pharmaceutical Ltd Unsponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
1,903
1,581
1,999
315,678
302,073
288,459
290,004
338,985
401,477
327,657
Gross Profit
1,263
1,094
1,442
231,460
207,772
200,636
201,936
236,997
298,034
233,163
Operating Income
114,337
101,550
158,321
160,407
121,061
136,651
127,683
182,270
172,469
165,657
EBITDA
129,511
100,273
158,721
160,806
153,866
137,050
137,091
178,997
208,838
174,619
Interest Expense
9
3
-
-
-
-
57
59
930
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
122,690
99,889
158,801
158,837
125,507
135,829
136,001
158,793
172,972
163,139
Income Tax Expense
31,484
25,488
46,941
49,341
33,948
38,595
38,846
45,640
48,653
45,601
Net Income
634
496
707
109,496
91,559
97,234
97,155
113,152
147,511
117,538
Net Profit Margin
33.31%
31.40%
35.41%
34.69%
30.31%
33.71%
33.50%
33.38%
36.74%
35.87%

Chugai Pharmaceutical Ltd Unsponsored ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
4,239
4,728
5,163
6,285
7,582
8,783
9,331
7,726
7,597
1,318,925
Gross Profit
2,101
2,478
2,822
3,848
4,947
5,812
5,804
4,853
5,394
937,603
Operating Income
76,884
98,934
124,323
210,597
301,230
421,897
533,309
439,174
542,002
618,804
EBITDA
93,253
115,268
121,560
234,419
328,726
450,301
564,743
470,914
573,667
661,976
Interest Expense
86
110
111
125
62
48
61
27
1,027
1,075
Depreciation
-
16,334
-
-
-
-
-
-
-
-
Income Before Tax
74,448
97,031
121,449
207,893
298,188
419,385
531,166
443,821
543,034
626,788
Income Tax Expense
20,076
23,490
28,370
50,333
83,455
116,390
156,737
118,349
155,717
171,734
Net Income
461
643
823
1,443
2,069
2,662
2,773
2,262
2,513
455,052
Net Profit Margin
10.90%
13.61%
15.95%
22.96%
27.29%
30.31%
29.72%
29.29%
33.09%
34.50%

Chugai Pharmaceutical Ltd Unsponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
74,401
111,860
109,496
91,559
97,234
97,155
113,152
130,728
117,538
Operating Cash Flow
100,913
70,650
123,643
152,394
66,677
821
75,218
135,085
125,670
Investing Cash Flow
-33,101
-140,646
-37,572
-16,903
-86,886
-334
93,511
-171,788
114,351
Financing Cash Flow
-66,872
-2,597
-69,506
-2,031
-95,378
-33
-212,787
654
-248,930
Change in Cash
4,189
-69,102
403,958
-403,958
423,419
609
-52,633
-57,870
-15,065

Chugai Pharmaceutical Ltd Unsponsored ADR Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
124,776
151,857
249,500
340,228
470,367
575,875
325,472
589,546
455,052
Operating Cash Flow
107,623
119,074
206,641
205,035
279,626
244,112
409,925
447,600
408,331
Investing Cash Flow
-36,718
-74,060
-81,741
-98,312
-118,927
-145,994
-37,290
-227,365
-214,805
Financing Cash Flow
-29,563
-35,014
-66,872
-99,497
-107,408
-145,641
-139,331
-141,006
-322,362
Change in Cash
43,706
7,786
57,081
8,392
55,420
-45,584
236,505
81,528
-112,250

Insights on Chugai Pharmaceutical Ltd Unsponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly & Co. has given 137.6% return, outperforming this stock by 81.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, AstraZeneca PLC has given 151.8% return, outperforming this stock by 159.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Chugai Pharmaceutical Ltd Unsponsored ADR Japan has experienced a decline in revenue for the last two quarters. The revenue decreased from $401.47 billion to $327.65 billion, resulting in an average decrease of 18.4% per quarter.

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Chugai Pharmaceutical Ltd's unsponsored ADR has seen a decline in net profit over the past two quarters. The profit dropped from $147.51 billion to $117.53 billion, which represents an average decrease of 20.3% each quarter.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, CHGCY stock has moved down by -20.0%

About Chugai Pharmaceutical Ltd Unsponsored ADR

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. It offers oncology products, such as Alecensa, Avastin, FoundationOne, Herceptin, Kadcyla, Lunsumio, Perjeta, Phesgo, Polivy, and Tecentriq; Actemra for humanized anti-human IL-6 receptor monoclonal antibody; CellCept, an immunosuppressant; Enspryng, a pH-dependent binding humanized anti-IL-6 receptor monoclonal antibody; Evrysdi, a spinal muscular atrophy agent; Hemlibra, an anti-coagulation factor IXa/X humanized bispecific monoclonal antibody; Mircera, an erythropoiesis-stimulating agent; PiaSky, a pH-dependent binding humanized anti-complement (C5) monoclonal antibody; Tamiflu, an anti-influenza agent; and Vabysmo, an anti VEGF/anti Ang-2 bispecific antibody. The company was formerly known as Chugai Shinyaku Shokai and changed its name to Chugai Pharmaceutical Co., Ltd. in January 1943. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding AG.
OrganisationChugai Pharmaceutical Ltd Unsponsored ADR
HeadquartersNihonbashi Mitsui Tower, Chuo, Japan, 103-8324
IndustryDrug Manufacturers - General
CEODr. Osamu Okuda
E-voting on sharesClick here to vote

Key Management of Chugai Pharmaceutical Ltd Unsponsored ADR

Name

Title

Toshiya Sasai

Executive of Investor Relations Group & Corporate Communications Department

Junichi Takano

Head of Marketing & Sales Division

Mr. Yoshiyuki Yano

Executive Vice President

Dr. Tomoyuki Igawa Ph.D.

VP & Head of Research Division

Dr. Kaori Ouchi

Executive Vice President

Dr. Osamu Okuda

President, CEO & Chairman

Mr. Iwaaki Taniguchi

Senior Executive Officer, CFO, Head of Finance & Director

Mr. Shinji Hidaka

Executive Vice President

Mr. Tetsuya Yamaguchi

Executive Vice President

Mr. Kosuke Iijima

Head of PHC Solution Department

FAQs

What is Chugai Pharmaceutical Ltd Unsponsored ADR share price today?

Chugai Pharmaceutical Ltd Unsponsored ADR share price today is $23.4 as on at the close of the market. Chugai Pharmaceutical Ltd Unsponsored ADR share today touched a day high of $23.96 and a low of $23.34.

What is the 52 week high and 52 week low for Chugai Pharmaceutical Ltd Unsponsored ADR share?

Chugai Pharmaceutical Ltd Unsponsored ADR share touched a 52 week high of $0 on and a 52 week low of $0 on . Chugai Pharmaceutical Ltd Unsponsored ADR stock price today i.e. is closed at $23.4,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Chugai Pharmaceutical Ltd Unsponsored ADR's market capitalisation today?

Chugai Pharmaceutical Ltd Unsponsored ADR market capitalisation is $0.08T as on .

How to invest in Chugai Pharmaceutical Ltd Unsponsored ADR Stock (CHGCY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Chugai Pharmaceutical Ltd Unsponsored ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Chugai Pharmaceutical Ltd Unsponsored ADR Shares that will get you 0.0641 shares as per Chugai Pharmaceutical Ltd Unsponsored ADR share price of $23.4 per share as on June 17, 2026 at 1:27 am IST.

What is the minimum amount required to buy Chugai Pharmaceutical Ltd Unsponsored ADR Stock (CHGCY) from India?

Indian investors can start investing in Chugai Pharmaceutical Ltd Unsponsored ADR (CHGCY) shares with as little as ₹94.5 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in Chugai Pharmaceutical Ltd Unsponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Chugai Pharmaceutical Ltd Unsponsored ADR share’s latest price of $23.4 as on June 17, 2026 at 1:27 am IST, you will get 0.4274 shares of Chugai Pharmaceutical Ltd Unsponsored ADR. Learn more about fractional shares .